Yanzhong Peng
Shenzhen, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Pradefovir Treatment in Patients With Chronic Hepatitis B: Week 24 Results From a Multicenter, Double-Blind, Randomized, Noninferiority, Phase 2 Trial.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: May 17, 2021
Rapidly decreased HBV RNA predicts responses of pegylated interferons in HBeAg-positive patients: a longitudinal cohort study.
Journal: Hepatology international
Published: August 22, 2019
Dahuang Zhechong pill attenuates CCl4-induced rat liver fibrosis via the PI3K-Akt signaling pathway.
Dahuang Zhechong pill attenuates CCl4-induced rat liver fibrosis via the PI3K-Akt signaling pathway.
Journal: Journal of cellular biochemistry
Published: November 06, 2018
Sofosbuvir-Based Therapies for Patients with Hepatitis C Virus Infection: Real-World Experience in China.
Journal: Canadian journal of gastroenterology & hepatology
Published: April 05, 2018
Effect of Dahuang Zhechong pills on long non-coding RNA growth arrest specific 5 in rat models of hepatic fibrosis.
Journal: Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan
Published: April 01, 2018
Genome‑wide identification of long noncoding RNAs in CCl4‑induced liver fibrosis via RNA sequencing.
Genome‑wide identification of long noncoding RNAs in CCl4‑induced liver fibrosis via RNA sequencing.
Journal: Molecular medicine reports
Published: March 21, 2017
Study of blood exposure-related mental health illness among clinical nurses.
Journal: Frontiers of medicine
Published: March 15, 2016
Correlation of the content of hepatitis B core antigen in peripheral blood mononuclear cells with HBV virus load.
Journal: Diagnostic microbiology and infectious disease
Published: January 12, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026